Alexion Pharmaceuticals, Inc.

SOROS FUND MANAGEMENT LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/13/2021

Shares

500,001

Value ($000)

91,855

Weight

1.7%

2021 Q2 - 2021 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/13/2021	91,855	1.7%	500,001	6/30/2021